Page last updated: 2024-08-21

hesperidin and oxidopamine

hesperidin has been researched along with oxidopamine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's3 (75.00)2.80

Authors

AuthorsStudies
Baluchnejadmojarad, T; Khalili, M; Kiasalari, Z; Roghani, M1
Antunes, MS; Araújo, SM; Boeira, SP; Bortolotto, VC; Cattelan Souza, L; Ladd, AABL; Ladd, FVL; Moreira, AL; Nogueira, CW; Prigol, M; Silva, MRP1
Elyasi, L; Hamid Abadi, HG; Jahanshahi, M; Jameie, M; Jameie, SB; Khalili, M; Nikmahzar, E1
Antunes, MS; Boeira, SP; Cattelan Souza, L; Ladd, AABL; Ladd, FVL; Moreira, AL1

Other Studies

4 other study(ies) available for hesperidin and oxidopamine

ArticleYear
Protective Effect of Oral Hesperetin Against Unilateral Striatal 6-Hydroxydopamine Damage in the Rat.
    Neurochemical research, 2016, Volume: 41, Issue:5

    Topics: Administration, Oral; Animals; Apoptosis; Corpus Striatum; Glial Fibrillary Acidic Protein; Gliosis; Hesperidin; Male; Neuroprotective Agents; NF-kappa B; Oxidative Stress; Oxidopamine; Parkinson Disease; Rats, Wistar

2016
Hesperidin Ameliorates Anxiety-Depressive-Like Behavior in 6-OHDA Model of Parkinson's Disease by Regulating Striatal Cytokine and Neurotrophic Factors Levels and Dopaminergic Innervation Loss in the Striatum of Mice.
    Molecular neurobiology, 2020, Volume: 57, Issue:7

    Topics: Animals; Anxiety; Behavior, Animal; Corpus Striatum; Cytokines; Depression; Dopaminergic Neurons; Hesperidin; Male; Mice; Nerve Growth Factors; Neuroprotective Agents; Oxidopamine; Parkinson Disease, Secondary

2020
6-OHDA mediated neurotoxicity in SH-SY5Y cellular model of Parkinson disease suppressed by pretreatment with hesperidin through activating L-type calcium channels.
    Journal of basic and clinical physiology and pharmacology, 2020, Sep-14, Volume: 32, Issue:2

    Topics: Apoptosis; Calcium; Calcium Channels, L-Type; Cell Line, Tumor; Cell Survival; Hesperidin; Humans; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Reactive Oxygen Species

2020
Hesperidin protects against behavioral alterations and loss of dopaminergic neurons in 6-OHDA-lesioned mice: the role of mitochondrial dysfunction and apoptosis.
    Metabolic brain disease, 2021, Volume: 36, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apoptosis; Behavior, Animal; Discrimination Learning; Dopamine; Dopaminergic Neurons; Hesperidin; Male; Maze Learning; Mice; Mitochondria; Motor Activity; NADH Dehydrogenase; Oxidopamine; Parkinson Disease, Secondary; Tyrosine 3-Monooxygenase

2021